Chemoprevention of breast cancer by fish oil in preclinical models: Trials and tribulations

Carina Signori, Karam El-Bayoumy, Jose Russo, Henry J. Thompson, John P. Richie, Terryl J. Hartman, Andrea Manni

Research output: Contribution to journalReview article

41 Citations (Scopus)

Abstract

Despite the perception that omega-3 fatty acids (n-3 FA) protect against breast cancer, epidemiologic studies have yielded inconsistent results. Although preclinical data have been, in general, more supportive of a protective effect of n-3 FA on breast cancer, inconsistencies still remain, which preclude definite conclusions or in-depth mechanistic investigations despite 30 years of research in this area. In this review, we discuss key variables that may account for inconsistencies of results across preclinical studies and provide recommendations for future experiments testing the chemopreventive effect of n-3 FAs in breast cancer, as part of a multiagent approach under rigorously controlled conditions.

Original languageEnglish (US)
Pages (from-to)6091-6096
Number of pages6
JournalCancer Research
Volume71
Issue number19
DOIs
StatePublished - Oct 1 2011

Fingerprint

Fish Oils
Chemoprevention
Breast Neoplasms
Omega-3 Fatty Acids
Epidemiologic Studies
Research

All Science Journal Classification (ASJC) codes

  • Oncology
  • Cancer Research

Cite this

Signori, Carina ; El-Bayoumy, Karam ; Russo, Jose ; Thompson, Henry J. ; Richie, John P. ; Hartman, Terryl J. ; Manni, Andrea. / Chemoprevention of breast cancer by fish oil in preclinical models : Trials and tribulations. In: Cancer Research. 2011 ; Vol. 71, No. 19. pp. 6091-6096.
@article{6447f47d389e4084b597dc528e165d42,
title = "Chemoprevention of breast cancer by fish oil in preclinical models: Trials and tribulations",
abstract = "Despite the perception that omega-3 fatty acids (n-3 FA) protect against breast cancer, epidemiologic studies have yielded inconsistent results. Although preclinical data have been, in general, more supportive of a protective effect of n-3 FA on breast cancer, inconsistencies still remain, which preclude definite conclusions or in-depth mechanistic investigations despite 30 years of research in this area. In this review, we discuss key variables that may account for inconsistencies of results across preclinical studies and provide recommendations for future experiments testing the chemopreventive effect of n-3 FAs in breast cancer, as part of a multiagent approach under rigorously controlled conditions.",
author = "Carina Signori and Karam El-Bayoumy and Jose Russo and Thompson, {Henry J.} and Richie, {John P.} and Hartman, {Terryl J.} and Andrea Manni",
year = "2011",
month = "10",
day = "1",
doi = "10.1158/0008-5472.CAN-11-0977",
language = "English (US)",
volume = "71",
pages = "6091--6096",
journal = "Cancer Research",
issn = "0008-5472",
number = "19",

}

Chemoprevention of breast cancer by fish oil in preclinical models : Trials and tribulations. / Signori, Carina; El-Bayoumy, Karam; Russo, Jose; Thompson, Henry J.; Richie, John P.; Hartman, Terryl J.; Manni, Andrea.

In: Cancer Research, Vol. 71, No. 19, 01.10.2011, p. 6091-6096.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Chemoprevention of breast cancer by fish oil in preclinical models

T2 - Trials and tribulations

AU - Signori, Carina

AU - El-Bayoumy, Karam

AU - Russo, Jose

AU - Thompson, Henry J.

AU - Richie, John P.

AU - Hartman, Terryl J.

AU - Manni, Andrea

PY - 2011/10/1

Y1 - 2011/10/1

N2 - Despite the perception that omega-3 fatty acids (n-3 FA) protect against breast cancer, epidemiologic studies have yielded inconsistent results. Although preclinical data have been, in general, more supportive of a protective effect of n-3 FA on breast cancer, inconsistencies still remain, which preclude definite conclusions or in-depth mechanistic investigations despite 30 years of research in this area. In this review, we discuss key variables that may account for inconsistencies of results across preclinical studies and provide recommendations for future experiments testing the chemopreventive effect of n-3 FAs in breast cancer, as part of a multiagent approach under rigorously controlled conditions.

AB - Despite the perception that omega-3 fatty acids (n-3 FA) protect against breast cancer, epidemiologic studies have yielded inconsistent results. Although preclinical data have been, in general, more supportive of a protective effect of n-3 FA on breast cancer, inconsistencies still remain, which preclude definite conclusions or in-depth mechanistic investigations despite 30 years of research in this area. In this review, we discuss key variables that may account for inconsistencies of results across preclinical studies and provide recommendations for future experiments testing the chemopreventive effect of n-3 FAs in breast cancer, as part of a multiagent approach under rigorously controlled conditions.

UR - http://www.scopus.com/inward/record.url?scp=80053381640&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=80053381640&partnerID=8YFLogxK

U2 - 10.1158/0008-5472.CAN-11-0977

DO - 10.1158/0008-5472.CAN-11-0977

M3 - Review article

C2 - 21933885

AN - SCOPUS:80053381640

VL - 71

SP - 6091

EP - 6096

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 19

ER -